Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYELOMA

ReachMD

Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma

Oncology, Medical July 18th 2022

Journal of Clinical Oncology

Modern Myeloma Therapy + Sustained Minimal Residual Disease–Negative = (Functional) Cure!

Oncology, Medical July 11th 2022

MashupMD

Multiple Myeloma with Manni Mohyuddin, MD

Oncology, Medical June 21st 2022

Journal of Clinical Oncology

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Oncology, Medical June 21st 2022

Journal of Clinical Oncology

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma

Oncology, Medical April 12th 2022

Journal of Clinical Oncology

Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy

Oncology, Medical March 29th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form